参与物
| 角色 | 名称 | HCID | 投料 |
|---|
| 反应物 | 三丁基膦 | HCID 13831 | — |
| 反应物 | 偶氮二甲酰二哌啶 | HCID 73042 | — |
| 反应物 | 2,2,2-Trichloroethyl isoxazol-3-ylcarbamate | HCID 1211419 | — |
| 反应物 | 3-(3-Fluoro-4-(imidazol-1-yl)phenyl)-5(R)-hydroxymethyloxazolidin-2-one | HCID 10492764 | — |
| 溶剂 | 四氢呋喃 | HCID 8028 | — |
| 产物 | (5S)-3-(3-fluoro-4-imidazol-1-yl-phenyl)-5-[(isoxazol-3-ylamino)methyl]oxazolidin-2-one | HCID 497417 | 158.5% |
反应步骤
3-(4-Imidazol-1-yl-3-fluorophenyl)-5(R)-hydroxymethyloxazolidin-2-one (693 mg, 2.5 mM, see WO 96-23788) and 3-(2,2,2-trichloroethyloxycarbonylamino)isoxazole (649 mg, 2.5 mM) were suspended by stirring in dry tetrahydrofuran (25 ml) under nitrogen in an ice-bath. Tributylphosphine (808 mg, 4 mM) was added followed by 1,1′-(azodicarbonyl)dipiperidine (945 mg, 3.75 nM) dissolved in tetrahydrofuran (10 ml) over 10 minutes. The mixture was then stirred 18 hours, allowing the temperature to rise to ambient, then filtered, and the filter cake washed with tetrahydrofuran. The combined filtrates were evaporated and the residue purified by chromatography on a 20 g silica Mega Bond Elut® column, eluting with a gradient increasing in polarity from 0 to 5% methanol in dichloromethane. Relevant fractions were combined, evaporated, and the residue triturated with diethyl ether to give the desired product (1.36 g), contaminated with tributylphosphine oxide.
来源与证据
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 专利号 | US07087629B2 |
|---|
| 来源数据集 | uspto-grants-2006_08 |
|---|
| ORD ID | ord-a99a9a93cf9f400f97f0c5d45b51636c |
|---|
| 来源说明 | uspto-grants-2006_08 |
|---|